scorecard

You Searched For "bharat biotech ceo" and got 17 results


Sort By:


Business Insider Latest Story Image
3 mins read

Rivals Serum Institute and Bharat Biotech come together after fear of ban on vaccine exports

Bharat Biotech CEO Krishna Ella and Serum Institute of India (SII) CEO Adar Poonawalla issued a joi…

Business Insider Latest Story Image
4 mins read

Bharat Biotech sees rivals’ conspiracy in all the criticism for the approval for Covaxin

Bharat Biotech chairman and managing director, Krishna Ella, believes that the gossip-mongering …

Business Insider Latest Story Image
2 mins read

Covaxin shows 77.8% effectiveness against symptomatic COVID-19 cases in phase-3 trials

The efficacy analysis demonstrates Covaxin to be 93.4 per cent effective against severe symptoma…

PTI   


Business Insider Latest Story Image
2 mins read

Around 10 crore doses of Covishield to be manufactured and supplied in June, says Serum Institute of India

In a recent letter to Union Home Minister Amit Shah, SII said its employees have been working …

PTI   


Business Insider Latest Story Image
8 mins read

COVID-19 vaccine updates in India: Oxford’s COVID-19 vaccine trials can be over by December, if SII doesn’t go for emergency licence

Scientists are still looking for a cure for the deadly coronavirus, which has infected millions of …

Business Insider Latest Story Image
4 mins read

Telangana yet to roll out the 'local' vaccine Bharat Biotech's Covaxin

Hyderabad, Telangana has still not rolled out Covaxin, developed by Hyderabad-based Bharat Biotech…

Business Insider Latest Story Image
1 min read

India's drug regulator asks Dr Reddy's for more data, as it reviews emergency use of Covid-19 vaccine Sputnik V

The Central Drug Standard Control Organisation's (CDSCO)Subject Expert Committee has asked Dr Reddy…

Business Insider Latest Story Image
2 mins read

India continues to mull over SII and Bharat Biotech's COVID-19 vaccine candidates

The Subject Expert Committee met on Wednesday to consider the Emergency Use Authorisation (EUA) …

Business Insider Latest Story Image
3 mins read

First consignment of COVID vaccines land in Hyderabad amid prayers, hopes

The much-awaited moment finally arrived on Tuesday as the first consignment of Covid-19 vaccine for…

Business Insider Latest Story Image
3 mins read

SII's Oxford-Astra Zeneca COVID-19 vaccine to cost $3-4 to Indian government, price likely to be double in private markets

Only after meeting their requirements, "the private market will open up where the pricin…

PTI   


Business Insider Latest Story Image
2 mins read

No vaccine approval yet, drug regulator analysing SII, Bharat Biotech data

New Delhi, Dec 30 (IANS) The analysis of the additional data and information submitted by Serum Ins…

Business Insider Latest Story Image
2 mins read

Bharat Biotech partners with Washington varsity for intranasal COVID-19 vaccine

The Hyderabad-based company owns the rights to distribute the vaccine in all markets except USA,…

Business Insider Latest Story Image
4 mins read

These are the seven Indian pharma players racing to develop COVID-19 vaccine

Vaccines normally require years of testing and additional time to produce at scale, but scientis…

Business Insider Latest Story Image
3 mins read

ICMR ‘clarifies’ that August 15 was not a deadline for COVID-19 vaccine after experts called out how impossible it was

Much like the rest of the world, India too is waiting with bated breath for a COVID-19 vaccine. Dru…

Business Insider Latest Story Image
2 mins read

Oxford COVID-19 vaccine may hit the Indian market by the end of the year if successful, says CEO of world’s largest vaccine manufacturer

World’s largest vaccine manufacturer, the Serum Institute of India (SSI), hopes oxford COVID-19 vac…

Business Insider Latest Story Image
2 mins read

Meet Neerja Sethi and Jayshree Ullal, who're on Forbes' richest, self-made women in the US list

India-born Neerja Sethi, with a net worth of USD 1.1 billion, has been ranked 14th on the list of t…

Business Insider Latest Story Image
1 min read

Ocugen jumps 27% after its COVID-19 vaccine shows potential effectiveness against virus variants

Studies have demonstrated Covaxin's potential effectiveness against coronavirus strains first seen …

Isabelle Lee